Skip to content
effecthub

BioSkepsis vs Elicit

Two fact sheets from our own research, side by side — pricing, platforms, API access and status re-checked by us rather than quoted from the vendors. BioSkepsis starts at $27, Elicit at $49. Both have a free tier. Only Elicit ships a public API.

BioSkepsisA life-sciences research assistant that searches 40M+ biomedical papers and returns cited, mechanism-level answers.ElicitLiterature review workflow that extracts data into tables

Side by side

FactBioSkepsisElicit
CategoryAcademic Search & Literature ReviewAcademic Search & Literature Review
Pricing modelFreemiumFreemium
Starts at$27 month$49 month
Public APINoYes
PlatformsWebWeb, API
CompanyEFEVRE TECH LTDElicit
Launched—2021
Last verifiedSep 1, 2026Sep 6, 2026

What our research says

BioSkepsis

Worth trying if literature review is a real bottleneck in your research — the citation-grounded answers and mechanism-level reasoning go further than a plain search summary. The free Basic tier has a monthly usage cap tight enough that regular users will likely need to upgrade to Plus or Pro within a few sessions.

Pros

  • searches over 40 million biomedical papers with citations attached
  • gives mechanism-level reasoning rather than a flat summary
  • exports full reports to PDF or Word with references included
  • free tier lets you test the workflow before paying

Cons

  • free tier's monthly usage cap is limiting for regular research work
  • pricing is in euros and scales quickly from Plus to Team plans
  • coverage is limited to life sciences, not a general research tool

Elicit

Elicit is the only one of these tools that treats a literature review as a structured extraction job rather than a chat, which is exactly right for the work. The price assumes you are billing someone else for the hours it saves.

Pros

  • Column-per-field extraction into a table is the correct shape for review work and rare elsewhere
  • Free tier is unusually generous: unlimited search, summaries and full-text chat
  • Every claim links back to the paper it came from
  • API access is included from the first paid tier rather than sold separately

Cons

  • The $49 to $169 jump is steep and Scale is priced for institutions, not labs
  • Free tier's limits on the Research Agent and Reports are not quantified anywhere on the pricing page
  • Extraction accuracy still needs spot-checking against the source PDF
  • Coverage is paper-centric, so grey literature and preprint-heavy fields are thinner

Which one fits

Choose BioSkepsis if you need

  • researchers doing systematic literature reviews across many papers
  • teams that need citations and traceable reasoning, not just a summary
  • life-science teams evaluating a hypothesis against existing evidence

Choose Elicit if you need

  • Systematic reviews and evidence synthesis where every included paper needs the same fields pulled
  • Researchers screening hundreds of abstracts against defined inclusion criteria
  • Pharma, policy and academic teams that need an auditable trail back to sources

More comparisons

All BioSkepsis alternatives →All Elicit alternatives →Browse all Academic Search & Literature Review →